She has played an active role during the COVID-19 pandemic as the UKRI’s COVID Response Director, and

., Jan. 19, 2022, today announced that TAVNEOS® (avacopan) has been approved within the European Union

March 2022 "February 17, 2022 08:00 AM Eastern Standard Time SAN FRANCISCO & SHANGHAI- ShouTi Inc.,

Agreement with Domain Therapeutics and Université de Montréal for GPCR-Targeted Drug Discovery " Apr.19.2022

August 2022 "August 12, 2022.- Jan Steyaert , scientific director of the VIB-VUB Center for Structural

. -11.6 placebo, p<0.0001) at Week 5 (Cohen’s d effect size of 0.61).

August 2022 "Geneva, Switzerland, August 18, 2022 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage

., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Trevena , Inc.

August 2022 "August 10, 2022 Cancer Research UK is working with global biopharma Sosei Heptares on

Allosteric Modulator Research Collaboration for Substance Use Disorders "Geneva, Switzerland, August 15 cough, in addition to the rights to develop certain retained compounds for Charcot-Marie-Tooth type 1A

The resulting homozygous hPTH1R-KI (humanized) mice were healthy over at least 10 generations and showed

July 2022 "July 19, 2022 07:00 AM Eastern Daylight Time BOSTON-- Tectonic Therapeutic , Inc. a pre-clinical

3,300,000 shares in the form of 550,000 American Depositary Shares (“ADSs”) at a gross purchase price of $1.70 , Addex has agreed to issue to Armistice Capital unregistered pre-funded warrants to purchase up to 11,700,000 shares in the form of 1,950,000 ADSs (the “Unregistered Pre-Funded Warrants”) at a funded amount of $1.69 with $0.01 payable on exercise as well as unregistered warrants to purchase up to 15,000,000 shares The Unregistered Warrants have an exercise price of $1.90 per ADS, will become exercisable in 60 days

He has led teams that have filed more than 10 Investigational New Drug Applications (IND), as well as

June 2022 "Ottawa, Canada, May 10, 2022 — Orion Biotechnology Canada Ltd, a drug discovery and development important new data at both LSX World Congress and TIDES USA 2022 conference, taking place this week – May 10 -12, 2022.

Data on Treatment of Adolescent Patients with Classic Congenital Adrenal Hyperplasia at ENDO 2022 "06/13 /22 - Substantial Reductions in Key Hormones and Hormone Precursors Observed After 14 Days of Crinecerfont years of age) and Adult (18 years of age and older) Patients with Classic CAH SAN DIEGO, June 13 from 11:00 a.m.–12:30 p.m. 11–14.

., 2017), with annual sales of GPCR-targeting drugs in 2018 accounting for >114 billion USD. Despite this high number of GPCR targeted drugs, only a small portion (∼110) of the human GPCRome (consisting

It has been awarded annually since 1985 to distinguished individuals who have strived, in an exceptional

May 2022 " MONTREAL (CANADA) – May 17, 2022 – Inversago Pharma Inc.

development of new gastrointestinal therapeutics Tokyo, Japan, Cambridge, UK and New York, USA – May 17

May 2022 "Published: May 10, 2022 To accelerate clinical development of its best-in-class and first-in-class

April 2022 "By Sophie Bradley | Apr 12, 2022 Summary Sophie Bradley, Translational Sciences Associate

April 2022 "SAN DIEGO, April 12, 2022 — Crinetics Pharmaceuticals , Inc. underwriting discounts and commissions and other offering expenses, are expected to be approximately $125.0 The offering is expected to close on or about April 18, 2022, subject to the satisfaction of customary

capabilities • ‘Venture-like’ capital allocation approach to focus pipeline development through to Phase 1b

Pre-series A Round to Accelerate Commercialization of Ultrahigh Throughput Drug Discovery Platform " April 12

Patient Enrollment For Dipraglurant Blepharospasm Phase 2 Clinical Study " Geneva, Switzerland, April 13

Strasbourg and Bordeaux, France, March 10, 2022 – Domain Therapeutics , a biopharmaceutical company specializing

Bryan Roth There are 10 open tickets available. Get yours now!